A phase I dose escalation, dose expansion and pharmacokinetic trial of gemcitabine and alisertib in advanced solid tumors and pancreatic cancer.
Chen JA, Huynh JC, Wu CY, Yu AM, Matsukuma K, Semrad TJ, Gandara DR, Li T, Riess JW, Tam K, Mack PC, Martinez A, Mahaffey N, Kelly KL, Kim EJ.
Chen JA, et al. Among authors: wu cy.
Cancer Chemother Pharmacol. 2022 Sep;90(3):217-228. doi: 10.1007/s00280-022-04457-9. Epub 2022 Jul 30.
Cancer Chemother Pharmacol. 2022.
PMID: 35907014
Free PMC article.
Clinical Trial.